Harnal Side Effects
|
|
Did You Have a Harnal Side Effect? How Effective is Harnal for You? |
Showing 1-25 of 146 Next Page >
Eye Pruritus, Conjunctivitis Allergic, Iritis, Glaucomatocyclitic Crises, Growth Of Eyelashes (8215308-1)
on Mar 07, 2012 Male patient from JAPAN , 82 years of age, was treated with Harnal D(View Usage). Patient experienced the following unwanted or unexpected effects: eye pruritus, conjunctivitis allergic, iritis, glaucomatocyclitic crises, growth of eyelashes. Harnal D dosage: Unk.
Patient was taking other medications:
Cardiac Failure, Pyrexia, Contusion (8008311-8)
Patient was taking Harnal D (View Usage). Patient had the following side effects: cardiac failure, pyrexia, contusion on Dec 21, 2011 from JAPAN Additional patient health information: Male patient , weighting 123.5 lb, . Harnal D dosage: N/A.
Patient was taking other medications:
Benign Prostatic Hyperplasia (7991529-8)
Adverse event was reported on Dec 13, 2011 by a Male patient taking Harnal D (View Usage) (Dosage: 0.2 Mg) was diagnosed with
Patient was taking other medications:
Gastric Ulcer, Anaemia, Bladder Transitional Cell Carcinoma, Blood Pressure Increased (7712540-8)
on Aug 05, 2011 Male patient from JAPAN , 84 years of age, was treated with Harnal D (tamsulosin Hydrochlirde) (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer, anaemia, bladder transitional cell carcinoma, blood pressure increased. Harnal D (tamsulosin Hydrochlirde) dosage: N/A.
Patient was taking other medications:
Blood Glucose Increased (7413121-6)
on Apr 05, 2011 Male patient from JAPAN , 79 years of age, was diagnosed with
Intervertebral Disc Protrusion (7401085-0)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). After Harnal was administered, patient had the following side effects: intervertebral disc protrusion on Mar 30, 2011 from JAPAN Additional patient health information: Male patient , weighting 138.2 lb, was diagnosed with
Diabetes Mellitus Inadequate Control (7366924-0)
Adverse event was reported on Mar 14, 2011 by a Male patient taking Harnal D (View Usage) (Dosage: N/A) . Location: JAPAN , 67 years of age, Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control.
Patient was taking other medications:
Diabetes Mellitus Inadequate Control (7361347-2)
on Mar 10, 2011 Male patient from JAPAN , 67 years of age, was treated with Harnal D (View Usage). Patient had the following side effects: diabetes mellitus inadequate control. Harnal D dosage: N/A.
Patient was taking other medications:
Dysuria (7328924-6)
on Feb 23, 2011 Male patient from JAPAN , 75 years of age, was diagnosed with
Patient was taking other medications:
Loss Of Consciousness, Fall (7325559-6)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, fall (fall Questions) on Feb 22, 2011 from JAPAN Additional patient health information: Male patient , 59 years of age, . Harnal (tamsulosin) Orodispersable Cr dosage: N/A.
Urinary Retention (7322869-3)
Adverse event was reported on Feb 21, 2011 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: N/A) . Location: JAPAN , 75 years of age, Patient had the following side effects: urinary retention.
Pneumonia Bacterial (7213053-2)
on Dec 28, 2010 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with
Patient was taking other medications:
Interstitial Lung Disease, Shock (6961635-5)
on Aug 24, 2010 Male patient from , 82 years of age, was treated with Harnal (tamsulosin) Orodispersable Cr(View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, shock. Harnal (tamsulosin) Orodispersable Cr dosage: N/A. Patient was hospitalized.
Urinary Retention (6876714-0)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient had the following side effects: urinary retention on Jul 20, 2010 from Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with
Patient was taking other medications:
Dementia (6876711-5)
Adverse event was reported on Jul 20, 2010 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: 0.2 Mg) . Location: , 69 years of age, After Harnal was administered, patient had the following side effects: dementia (dementia Questions).
Patient was taking other medications:
Dementia (6840815-3)
on Jul 06, 2010 Male patient from , 69 years of age, was treated with Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (dementia Questions). Harnal (tamsulosin) Orodispersable Cr dosage: 0.2 Mg.
Patient was taking other medications:
Urinary Retention (6809463-5)
on Jun 22, 2010 Male patient from , weighting 127.9 lb, was diagnosed with
Patient was taking other medications:
Hepatic Function Abnormal, Pneumonia, Residual Urine (6578429-5)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). After Harnal was administered, patient had the following side effects: hepatic function abnormal, pneumonia (pneumonia Questions), residual urine on Feb 05, 2010 from Additional patient health information: Male patient , 82 years of age, was diagnosed with
Patient was taking other medications:
Hepatic Function Abnormal, Residual Urine (6386872-2)
Adverse event was reported on Sep 25, 2009 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Hepatic Function Abnormal (6377694-7)
on Sep 17, 2009 Male patient from , 55 years of age, was treated with Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient had the following side effects: hepatic function abnormal. Harnal (tamsulosin) Orodispersable Cr dosage: N/A.
Patient was taking other medications:
Cognitive Disorder (6358224-2)
on Sep 10, 2009 Male patient from , weighting 176.4 lb, was diagnosed with
Patient was taking other medications:
Interstitial Lung Disease (6357000-4)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Sep 09, 2009 from Additional patient health information: Male patient , 56 years of age, . Harnal (tamsulosin) Orodispersable Cr dosage: N/A.
Hepatic Function Abnormal (6355168-7)
Adverse event was reported on Sep 08, 2009 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: N/A) . Location: , 55 years of age, Patient had the following side effects: hepatic function abnormal.
Patient was taking other medications:
Pustular Psoriasis (6347377-8)
on Sep 08, 2009 Male patient from GERMANY , 66 years of age, was diagnosed with
Patient was taking other medications:
Pustular Psoriasis (6339538-9)
on Aug 21, 2009 Male patient from GERMANY , 66 years of age, was diagnosed with
Patient was taking other medications:
on Mar 07, 2012 Male patient from JAPAN , 82 years of age, was treated with Harnal D(View Usage). Patient experienced the following unwanted or unexpected effects: eye pruritus, conjunctivitis allergic, iritis, glaucomatocyclitic crises, growth of eyelashes. Harnal D dosage: Unk.
Patient was taking other medications:
- NE SOFT (Unk) (View Ne Soft Review and Ne Soft Label )
- LUMIGAN (1 Gtt, Qpm) (View Lumigan Review and Lumigan Label )
- MIKELAN LA (Unk) (View Mikelan La Review and Mikelan La Label )
- MECOBAMIDE (Unk) (View Mecobamide Review and Mecobamide Label )
- LATANOPROST (Unk) (View Latanoprost Review and Latanoprost Label )
- ODOMEL (Unk) (View Odomel Review and Odomel Label )
- LEDOLPER (Unk) (View Ledolper Review and Ledolper Label )
- BICALUTAMIDE (Unk) (View Bicalutamide Review and Bicalutamide Label )
Cardiac Failure, Pyrexia, Contusion (8008311-8)
Patient was taking Harnal D (View Usage). Patient had the following side effects: cardiac failure, pyrexia, contusion on Dec 21, 2011 from JAPAN Additional patient health information: Male patient , weighting 123.5 lb, . Harnal D dosage: N/A.
Patient was taking other medications:
- CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label )
- FLUOROURACIL (Stop Date: May 2011.) (View Fluorouracil Review and Fluorouracil Label )
Benign Prostatic Hyperplasia (7991529-8)
Adverse event was reported on Dec 13, 2011 by a Male patient taking Harnal D (View Usage) (Dosage: 0.2 Mg) was diagnosed with
- benign prostatic hyperplasia
- type 2 diabetes mellitus
Patient was taking other medications:
- BI 1356 (5 Mg) (View Bi 1356 Review and Bi 1356 Label )
- BASEN (0.9 Mg) (View Basen Review and Basen Label )
Gastric Ulcer, Anaemia, Bladder Transitional Cell Carcinoma, Blood Pressure Increased (7712540-8)
on Aug 05, 2011 Male patient from JAPAN , 84 years of age, was treated with Harnal D (tamsulosin Hydrochlirde) (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer, anaemia, bladder transitional cell carcinoma, blood pressure increased. Harnal D (tamsulosin Hydrochlirde) dosage: N/A.
Patient was taking other medications:
- NORVASC (View Norvasc Review and Norvasc Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
- AMARYL (View Amaryl Review and Amaryl Label )
- DIOVAN (View Diovan Review and Diovan Label )
- ISODADOL (DIFENIDOL HYDROCHLORIDE) (View Isodadol (difenidol Hydrochloride) Review and Isodadol (difenidol Hydrochloride) Label )
- ACTOS (15 Mg (15 Mg, 1 In 1 D) Per Oral) (View Actos Review and Actos Label )
Blood Glucose Increased (7413121-6)
on Apr 05, 2011 Male patient from JAPAN , 79 years of age, was diagnosed with
- benign prostatic hyperplasia
Intervertebral Disc Protrusion (7401085-0)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). After Harnal was administered, patient had the following side effects: intervertebral disc protrusion on Mar 30, 2011 from JAPAN Additional patient health information: Male patient , weighting 138.2 lb, was diagnosed with
- benign prostatic hyperplasia
Diabetes Mellitus Inadequate Control (7366924-0)
Adverse event was reported on Mar 14, 2011 by a Male patient taking Harnal D (View Usage) (Dosage: N/A) . Location: JAPAN , 67 years of age, Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control.
Patient was taking other medications:
- INSULIN (View Insulin Review and Insulin Label )
- AVOLVE (View Avolve Review and Avolve Label )
- VESICARE (View Vesicare Review and Vesicare Label )
Diabetes Mellitus Inadequate Control (7361347-2)
on Mar 10, 2011 Male patient from JAPAN , 67 years of age, was treated with Harnal D (View Usage). Patient had the following side effects: diabetes mellitus inadequate control. Harnal D dosage: N/A.
Patient was taking other medications:
- VESICARE (View Vesicare Review and Vesicare Label )
- INSULIN (View Insulin Review and Insulin Label )
- AVOLVE (View Avolve Review and Avolve Label )
Dysuria (7328924-6)
on Feb 23, 2011 Male patient from JAPAN , 75 years of age, was diagnosed with
- benign prostatic hyperplasia
Patient was taking other medications:
- LISINOPRIL (View Lisinopril Review and Lisinopril Label )
- NORVASC (View Norvasc Review and Norvasc Label )
Loss Of Consciousness, Fall (7325559-6)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, fall (fall Questions) on Feb 22, 2011 from JAPAN Additional patient health information: Male patient , 59 years of age, . Harnal (tamsulosin) Orodispersable Cr dosage: N/A.
Urinary Retention (7322869-3)
Adverse event was reported on Feb 21, 2011 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: N/A) . Location: JAPAN , 75 years of age, Patient had the following side effects: urinary retention.
Pneumonia Bacterial (7213053-2)
on Dec 28, 2010 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with
- prostate cancer (prostate cancer Questions)
- emphysema
Patient was taking other medications:
- SPIRIVA (18mcg Per Day) (View Spiriva Review and Spiriva Label )
- UNIPHYL (400mg Per Day) (View Uniphyl Review and Uniphyl Label )
- SERETIDE (500mcg Per Day) (View Seretide Review and Seretide Label )
Interstitial Lung Disease, Shock (6961635-5)
on Aug 24, 2010 Male patient from , 82 years of age, was treated with Harnal (tamsulosin) Orodispersable Cr(View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, shock. Harnal (tamsulosin) Orodispersable Cr dosage: N/A. Patient was hospitalized.
Urinary Retention (6876714-0)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient had the following side effects: urinary retention on Jul 20, 2010 from Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with
- benign prostatic hyperplasia
Patient was taking other medications:
- GOSHAJINKIGAN (HERBAL EXTRACT NOS) (View Goshajinkigan (herbal Extract Nos) Review and Goshajinkigan (herbal Extract Nos) Label )
- UBRETID (DISTIGMINE BROMIDE) (5 Mg) (View Ubretid (distigmine Bromide) Review and Ubretid (distigmine Bromide) Label )
- LEVOTHYROXINE SODIUM (25 Mg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label )
- NOVOLOG (View Novolog Review and Novolog Label )
- VOGLIBOSE (VOGLIBOSE) (View Voglibose (voglibose) Review and Voglibose (voglibose) Label )
- CHOREITOUGOUSHIMOTSUTOU (HERBAL EXTRACT NOS) (View Choreitougoushimotsutou (herbal Extract Nos) Review and Choreitougoushimotsutou (herbal Extract Nos) Label )
Dementia (6876711-5)
Adverse event was reported on Jul 20, 2010 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: 0.2 Mg) . Location: , 69 years of age, After Harnal was administered, patient had the following side effects: dementia (dementia Questions).
Patient was taking other medications:
- AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label )
- CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label )
- ARICEPT (View Aricept Review and Aricept Label )
- DISOPAIN (MOFEZOLAC) (View Disopain (mofezolac) Review and Disopain (mofezolac) Label )
- SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label )
- VOLTAREN (View Voltaren Review and Voltaren Label )
Dementia (6840815-3)
on Jul 06, 2010 Male patient from , 69 years of age, was treated with Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (dementia Questions). Harnal (tamsulosin) Orodispersable Cr dosage: 0.2 Mg.
Patient was taking other medications:
- AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label )
- CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label )
- ARICEPT (View Aricept Review and Aricept Label )
Urinary Retention (6809463-5)
on Jun 22, 2010 Male patient from , weighting 127.9 lb, was diagnosed with
- benign prostatic hyperplasia
Patient was taking other medications:
- GOSHAJINKIGAN (HERBAL EXTRACT NOS) (View Goshajinkigan (herbal Extract Nos) Review and Goshajinkigan (herbal Extract Nos) Label )
- UBRETID (DISTIGMINE BROMIDE) (5 Mg) (View Ubretid (distigmine Bromide) Review and Ubretid (distigmine Bromide) Label )
- LEVOTHYROXINE SODIUM (25 Mg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label )
- NOVOLOG (View Novolog Review and Novolog Label )
- VOGLIBOSE (VOGLIBOSE) (View Voglibose (voglibose) Review and Voglibose (voglibose) Label )
- CHOREITOUGOUSHIMOTSUTOU (HERBAL EXTRACT NOS) (View Choreitougoushimotsutou (herbal Extract Nos) Review and Choreitougoushimotsutou (herbal Extract Nos) Label )
Hepatic Function Abnormal, Pneumonia, Residual Urine (6578429-5)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). After Harnal was administered, patient had the following side effects: hepatic function abnormal, pneumonia (pneumonia Questions), residual urine on Feb 05, 2010 from Additional patient health information: Male patient , 82 years of age, was diagnosed with
- residual urine
- hypertonic bladder
Patient was taking other medications:
- SOLIFENACIN (2.5 Mg) (View Solifenacin Review and Solifenacin Label )
Hepatic Function Abnormal, Residual Urine (6386872-2)
Adverse event was reported on Sep 25, 2009 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: N/A) was diagnosed with
- residual urine
- hypertonic bladder
Patient was taking other medications:
- SOLIFENACIN (2.5 Mg) (View Solifenacin Review and Solifenacin Label )
Hepatic Function Abnormal (6377694-7)
on Sep 17, 2009 Male patient from , 55 years of age, was treated with Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient had the following side effects: hepatic function abnormal. Harnal (tamsulosin) Orodispersable Cr dosage: N/A.
Patient was taking other medications:
- MYSLEE (ZOLPIDEM) (View Myslee (zolpidem) Review and Myslee (zolpidem) Label )
- MEILAX (ETHYL LOFLAZEPATE) (View Meilax (ethyl Loflazepate) Review and Meilax (ethyl Loflazepate) Label )
- VFEND (View Vfend Review and Vfend Label )
- GASCON (DIMETICONE) (View Gascon (dimeticone) Review and Gascon (dimeticone) Label )
- AMOBAN (ZOPICLONE) (View Amoban (zopiclone) Review and Amoban (zopiclone) Label )
- SP TROCHE (DEQUALINIUM CHLORIDE) (View Sp Troche (dequalinium Chloride) Review and Sp Troche (dequalinium Chloride) Label )
- DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label )
- SENNOSIDE (SENNOSIDE A+B) (View Sennoside (sennoside A+b) Review and Sennoside (sennoside A+b) Label )
Cognitive Disorder (6358224-2)
on Sep 10, 2009 Male patient from , weighting 176.4 lb, was diagnosed with
- benign prostatic hyperplasia
- hypertonic bladder
Patient was taking other medications:
- VESICARE (5 Mg) (View Vesicare Review and Vesicare Label )
Interstitial Lung Disease (6357000-4)
Patient was taking Harnal (tamsulosin) Orodispersable Cr (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Sep 09, 2009 from Additional patient health information: Male patient , 56 years of age, . Harnal (tamsulosin) Orodispersable Cr dosage: N/A.
Hepatic Function Abnormal (6355168-7)
Adverse event was reported on Sep 08, 2009 by a Male patient taking Harnal (tamsulosin) Orodispersable Cr (View Usage) (Dosage: N/A) . Location: , 55 years of age, Patient had the following side effects: hepatic function abnormal.
Patient was taking other medications:
- MYSLEE (ZOLPIDEM) (View Myslee (zolpidem) Review and Myslee (zolpidem) Label )
- MEILAX (ETHYL LOFLAZEPATE) (View Meilax (ethyl Loflazepate) Review and Meilax (ethyl Loflazepate) Label )
- VFEND (View Vfend Review and Vfend Label )
- GASCON (DIMETICONE) (View Gascon (dimeticone) Review and Gascon (dimeticone) Label )
- AMOBAN (ZOPICLONE) (View Amoban (zopiclone) Review and Amoban (zopiclone) Label )
- SP TROCHE (DEQUALINIUM CHLORIDE) (View Sp Troche (dequalinium Chloride) Review and Sp Troche (dequalinium Chloride) Label )
- DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label )
- SENNOSIDE (SENNOSIDE A+B) (View Sennoside (sennoside A+b) Review and Sennoside (sennoside A+b) Label )
Pustular Psoriasis (6347377-8)
on Sep 08, 2009 Male patient from GERMANY , 66 years of age, was diagnosed with
- benign prostatic hyperplasia
- gastric ulcer
- myocardial infarction
Patient was taking other medications:
- PROMAC (View Promac Review and Promac Label )
- AMLODIPINE (View Amlodipine Review and Amlodipine Label )
- GASTER D (View Gaster D Review and Gaster D Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
- PLAVIX (View Plavix Review and Plavix Label )
- NEORAL (View Neoral Review and Neoral Label )
- ZYLORIC (View Zyloric Review and Zyloric Label )
- LOCHOL (View Lochol Review and Lochol Label )
Pustular Psoriasis (6339538-9)
on Aug 21, 2009 Male patient from GERMANY , 66 years of age, was diagnosed with
- benign prostatic hyperplasia
- gastric ulcer
- myocardial infarction
Patient was taking other medications:
- PROMAC (View Promac Review and Promac Label )
- AMLODIPINE (View Amlodipine Review and Amlodipine Label )
- GASTER D (View Gaster D Review and Gaster D Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
- PLAVIX (View Plavix Review and Plavix Label )
- NEORAL (View Neoral Review and Neoral Label )
- ZYLORIC (View Zyloric Review and Zyloric Label )
- LOCHOL (View Lochol Review and Lochol Label )
Showing 1-25 of 146 Next Page >
Harnal Forum
i took tamsulosin and just got a fever afterwards...my doctor ...Keep Reading
I take harnal before going to bed but I work up 3-4 times to ...Keep Reading
Guten Tag, Harnal 0.2 mg hilft ueberhaupt nicht, das ist ein grosser ...Keep Reading
i just wanna get ur experience abt taking harnal, my doctor ask me ...Keep Reading
easy totake orally. pleasant taste. hope it does control bhp....Keep Reading
Harnal Adverse Effect Reports (FDA)
Harnal InformationSide Effects reported to FDA: 146. View FDA Adverse Reports Harnal safety alerts: No Reported deaths: 11 Reported hospitalizations: 29
| ||||||||||||||||||||||